PlumX Metrics
Embed PlumX Metrics

PrEP for HIV Prevention: Evidence, Global Scale-up, and Emerging Options

Cell Host & Microbe, ISSN: 1931-3128, Vol: 27, Issue: 4, Page: 502-506
2020
  • 38
    Citations
  • 0
    Usage
  • 83
    Captures
  • 3
    Mentions
  • 16
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

  • Citations
    38
  • Captures
    83
  • Mentions
    3
    • News Mentions
      3
      • 3
  • Social Media
    16
    • Shares, Likes & Comments
      16
      • Facebook
        16

Most Recent News

Gates Foundation gives $122M for Univ. of Washington study on monthly HIV pill

Researchers at the University of Washington will test a once-a-month pill to prevent HIV in women with a new $122 million grant from the Bill

Article Description

Antiretroviral pre-exposure prophylaxis (PrEP) for the prevention of HIV infection was demonstrated to be efficacious and safe earlier this decade from pivotal studies using oral emtricitabine-tenofovir disoproxil fumarate. Regulatory approval and normative guidance, now for almost 70 countries worldwide, has followed. Demonstration projects have shown high uptake and population-level HIV reductions, highlighting the need for simplifying delivery and reducing current barriers to access and persistence. A portfolio of additional, next-generation PrEP formulations, currently under testing, if effective, will offer users choice and likely increase coverage and impact.

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know